277 related articles for article (PubMed ID: 31983061)
1. The Future of Precision Oncology for the Treatment of Solid Tumors.
Klute KA
Clin Pharmacol Ther; 2020 Sep; 108(3):416-418. PubMed ID: 31983061
[No Abstract] [Full Text] [Related]
2. Molecular pathology in therapeutics: where are we now, and where are we going?
Harrison DJ; Faratian D
Curr Drug Targets; 2012 Nov; 13(12):1473-4. PubMed ID: 22974390
[No Abstract] [Full Text] [Related]
3. Precision cancer medicine: the future is now, only better.
Tsimberidou AM; Eggermont AM; Schilsky RL
Am Soc Clin Oncol Educ Book; 2014; ():61-9. PubMed ID: 24857061
[TBL] [Abstract][Full Text] [Related]
4. Giving Up on Precision Oncology? Not So Fast!
Warner JL
Clin Transl Sci; 2017 May; 10(3):128-129. PubMed ID: 28146309
[No Abstract] [Full Text] [Related]
5. Precision and predictive medicine in urothelial cancer: are we making progress?
Bellmunt J; Orsola A; Sonpavde G
Eur Urol; 2015 Oct; 68(4):547-9. PubMed ID: 25935702
[TBL] [Abstract][Full Text] [Related]
6. Evidence-Based Development and Clinical Use of Precision Oncology Therapeutics.
Comment LA; Ward AF; Schrock AB; Fabrizio D; Venstrom JM; Hegde PS; Alexander BM
Clin Pharmacol Ther; 2020 Sep; 108(3):440-443. PubMed ID: 32744335
[No Abstract] [Full Text] [Related]
7. Lack of access to targeted cancer therapy.
Burki TK
Lancet Oncol; 2015 Oct; 16(13):e482. PubMed ID: 26321211
[No Abstract] [Full Text] [Related]
8. Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial.
Le Tourneau C; Delord JP; Gonçalves A; Gavoille C; Dubot C; Isambert N; Campone M; Trédan O; Massiani MA; Mauborgne C; Armanet S; Servant N; Bièche I; Bernard V; Gentien D; Jezequel P; Attignon V; Boyault S; Vincent-Salomon A; Servois V; Sablin MP; Kamal M; Paoletti X;
Lancet Oncol; 2015 Oct; 16(13):1324-34. PubMed ID: 26342236
[TBL] [Abstract][Full Text] [Related]
9. National Cancer Institute's Precision Medicine Initiatives for the new National Clinical Trials Network.
Abrams J; Conley B; Mooney M; Zwiebel J; Chen A; Welch JJ; Takebe N; Malik S; McShane L; Korn E; Williams M; Staudt L; Doroshow J
Am Soc Clin Oncol Educ Book; 2014; ():71-6. PubMed ID: 24857062
[TBL] [Abstract][Full Text] [Related]
10. Steps forward for cancer precision medicine.
Salgado R; Moore H; Martens JWM; Lively T; Malik S; McDermott U; Michiels S; Moscow JA; Tejpar S; McKee T; Lacombe D;
Nat Rev Drug Discov; 2018 Jan; 17(1):1-2. PubMed ID: 29170471
[TBL] [Abstract][Full Text] [Related]
11. Precision Medicine.
Khatri VP; Petrelli NJ
Surg Oncol Clin N Am; 2020 Jan; 29(1):xv-xvi. PubMed ID: 31757318
[No Abstract] [Full Text] [Related]
12. New developments on targeted cancer therapy: Multi-faceted issues in targeted cancer therapy.
Bao J; Qiao L
Cancer Lett; 2017 Feb; 387():1-2. PubMed ID: 28038727
[No Abstract] [Full Text] [Related]
13. Strategies in functional proteomics: Unveiling the pathways to precision oncology.
Favicchio R; Thepaut C; Zhang H; Arends R; Stebbing J; Giamas G
Cancer Lett; 2016 Nov; 382(1):86-94. PubMed ID: 26850375
[TBL] [Abstract][Full Text] [Related]
14. Present and future molecular testing of lung carcinoma.
Dacic S; Nikiforova MN
Adv Anat Pathol; 2014 Mar; 21(2):94-9. PubMed ID: 24508692
[TBL] [Abstract][Full Text] [Related]
15. Precision Medicine in Pediatric Oncology.
Vo KT; Parsons DW; Seibel NL
Surg Oncol Clin N Am; 2020 Jan; 29(1):63-72. PubMed ID: 31757314
[TBL] [Abstract][Full Text] [Related]
16. Precision oncology: where next?
Gore M; Larkin J
Lancet Oncol; 2015 Dec; 16(16):1593-5. PubMed ID: 26678189
[No Abstract] [Full Text] [Related]
17. Precision medicine in pediatric oncology.
Forrest SJ; Geoerger B; Janeway KA
Curr Opin Pediatr; 2018 Feb; 30(1):17-24. PubMed ID: 29189430
[TBL] [Abstract][Full Text] [Related]
18. The Changing Face of Oncology Research, Drug Development, and Clinical Practice: Toward Patient-Focused Precision Therapeutics.
Venkatakrishnan K; van der Graaf PH; Holstein SA
Clin Pharmacol Ther; 2020 Sep; 108(3):399-404. PubMed ID: 33439492
[No Abstract] [Full Text] [Related]
19. Precision medicine: lessons learned from the SHIVA trial.
Weiss GJ
Lancet Oncol; 2015 Dec; 16(16):e580. PubMed ID: 26678199
[No Abstract] [Full Text] [Related]
20. Precision medicine: lessons learned from the SHIVA trial.
Hahn AW; Martin MG
Lancet Oncol; 2015 Dec; 16(16):e580-1. PubMed ID: 26678198
[No Abstract] [Full Text] [Related]
[Next] [New Search]